NYMC Faculty Publications

Botulinum Toxin: A Potential Cardiovascular Agent?

Author Type(s)

Faculty

DOI

10.1097/CRD.0000000000000582

Journal Title

Cardiology in Review

First Page

88

Last Page

92

Document Type

Article

Publication Date

1-1-2025

Department

Medicine

Keywords

atrial fibrillation, BoNT, botulinum neurotoxin, heart failure, hypertension, ischemia-reperfusion injury

Disciplines

Medicine and Health Sciences

Abstract

Botulinum neurotoxin (BoNT) is a toxin with a wide repertoire of well-known applications in cosmetics and medicine, such as treating migraine headaches, spasticity, and achalasia, and it has generally been shown to be safe and well-tolerated. In addition to its current successes in clinical practice, studies have also demonstrated the potential of BoNT to be used as a therapeutic agent for many cardiovascular conditions. Prior investigations, as well as trials currently underway, have showcased the safety and potential efficacy of BoNT in applications such as treating ischemia-reperfusion injury, hypertension, atrial fibrillation, and heart failure. While further study in humans, as well as improved statistical power in efficacy studies, are needed before its prospective use as a treatment for the aforementioned conditions, one might consider BoNT a potential cardiovascular agent.

Link to Full Text

Share

COinS